Halozyme and Genentech to Collaborate on Clinical Cancer Trials
Halozyme Therapeutics Inc. has partnered with Genentech to conduct clinical studies to evaluate Halozyme’s investigational drug PEGPH20 in six tumor types, starting... Read More
For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org
Together, we will defeat stomach cancer.
Together, we will defeat stomach cancer.
MORE INFODONATE